Rou-Min Wang

Dr. Rou-Min Wang

Second Affiliated Hospital of Zhejiang University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2019 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
QWQiao Wei
Qiao Wei
HDHai-Lin Dong
Hai-Lin Dong
LPLi-Ying Pan
Li-Ying Pan
CCCongxin Chen
Congxin Chen
YYYang-Tian Yan
Yang-Tian Yan
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
Although many causative genes of hereditary spastic paraplegia (HSP) have been uncovered in recent years, there are still approximately 50% of HSP patients without genetically diagnosis, especially in autosomal recessive (AR) HSP patients. Rare studies have been performed to determine the genetic spectrum and clinical profiles of recessive HSP patients in the Chinese population. In this study, we investigated 24 Chinese index AR/sporadic patients by targeted next-generation sequencing (NGS), Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Further functional studies were performed to identify pathogenicity of those uncertain significance variants. We identified 11 mutations in HSP related genes including 7 novel mutations, including two (p.V1979_L1980delinsX, p.F2343 fs) in SPG11, two (p.T55 M, p.S308 T) in AP5Z1, one (p.S242 N) in ALDH18A1, one (p.D597fs) in GBA2, and one (p.Q486X) in ATP13A2 in 8 index patients and their family members. Mutations in ALDH18A1, AP5Z1, CAPN1 and ATP13A2 genes were firstly reported in the Chinese population. Furthermore, the clinical phenotypes of the patients carrying mutations were described in detail. The mutation (p.S242 N) in ALDH18A1 decreased enzyme activity of P5CS and mutations (p.T55 M, p.S308 T) in AP5Z1 induced lysosomal dysfunction. Our results expanded the genetic spectrum and clinical profiles of AR-HSP patients and further demonstrated the efficiency and reliability of targeted NGS diagnosing suspected HSP patients.

1 March 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YDYi Dong
Yi Dong
Rou-Min WangRou-Min Wang
Rou-Min Wang
Guo-Min YangGuo-Min Yang
Guo-Min Yang
HYHao Yu
Hao Yu
WXWan-Qing Xu
Wan-Qing Xu
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

4 November 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
WXWan-Qing Xu
Wan-Qing Xu
Rou-Min WangRou-Min Wang
Rou-Min Wang
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

25 February 2021 in Genes
Verified
Journal Article
Open access
PDF file
Guo-Min YangGuo-Min Yang
Guo-Min Yang
Rou-Min WangRou-Min Wang
Rou-Min Wang
Nan XiaNan Xia
Nan Xia
ziwei zhengziwei zheng
ziwei zheng
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
Wilson’s disease (WD) is an autosomal recessive disorder caused by ATP7B pathogenic variants. This study aimed to show the geographical distribution and haplotype spectrum of three prevalent pathogenic variants (p.R778L, p.P992L, p.T935M) in mainland Chinese population and clarify whether the founder effect may account for their origins. We firstly summarized the frequency and geographical distribution of p.R778L, p.P992L and p.T935M in 715 WD patients. Then, to construct haplotypes associated with the three variants, Sanger sequencing and microsatellite typing at three dinucleotide-repeat markers (D13S314, D13S301, D13S316) flanking the ATP7B gene were performed in 102 WD families. An obvious regional-specific distribution feature was found in p.T935M. Linkage disequilibrium at the three markers was shown in all the three variants and we found the common haplotypes specific for p.R778L, p.P992L and p.T935M respectively, represented successively by 10-7-7, 10-9-5 and 12-4-8, which all exhibited great significance vs. the control chromosomes (p < 0.01). Meanwhile, haplotypes for the three variants differed from the studies in other regions to some extent. The common haplotypes we found indicate that three prevalent pathogenic variants emerge due to the founder effect. Furthermore, the study contributes to expand our knowledge of the genetic diversity of WD from a cross-regional perspective.

4 August 2021 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
WXWan-Qing Xu
Wan-Qing Xu
WNWang Ni
Wang Ni
Rou-Min WangRou-Min Wang
Rou-Min Wang
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

13 April 2020 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
Rou-Min WangRou-Min Wang
Rou-Min Wang
HYHao Yu
Hao Yu
GYGuo‐Min Yang
Guo‐Min Yang
WXWan‐Qing Xu
Wan‐Qing Xu
NXNan Xia
Nan Xia
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
Objective Generalized epilepsy is rarely reported in patients with Wilson disease (WD) and lacks experience in clinical practice. We aim to provide better experience for the diagnosis and treatment for WD patients with epilepsy in the future. Methods A retrospective study was performed in 13 Chinese WD patients with generalized epilepsy. Each patient was diagnosed with WD by clinical evaluation and genetic screening. Patients were given small doses of antiepileptic drugs (AEDs), followed by copper‐chelation therapy when the seizures stabilized. Clinical manifestations, brain imaging changes, and treatment and outcome after a long‐term follow‐up were analyzed. Results Four out of 13 (30.8%) patients stopped taking copper‐chelation drugs for more than 1 year before they were admitted for epilepsy. The incidence of epilepsy of WD patients in our cohort is 1.43% (13/910), lower than those (4.5%‐5.9%) in other populations. After the attack of epilepsy, frontal lobes were the most common abnormalities (13/13, 100%) in patients, followed by brain stem (8/13, 61.5%) and thalamus (7/13, 53.8%). After a long‐term follow‐up, brain imaging and clinical manifestations of 8 (8/9, 88.9%) WD patients were significantly improved. Conclusions We firstly described WD patients with generalized epilepsy in the Chinese population. WD patients with aggravation of neuropsychiatric symptoms are prone to occur epilepsy; thus, brain MRI should be performed regularly in those patients. Cortical abnormality in brain MRI is a warning sign of epilepsy. Irregular use of copper‐chelation drugs and excessive copper deposition in the brain may be the cause of seizures. Long‐term standardized treatment for WD can effectively prevent the extensive brain damage and reduce the incidence of epilepsy in WD patients.